Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Zimmer Biomet logoZimmer Biomet ZBH

On September 4, 2025, Zimmer Biomet issued 2 series of senior unsecured debt securities denominated in Swiss francs, comprising CHF 210,000,000 aggregate principal amount of the Company's 0.930% Bonds 2025 – 2030 (Tranche A) and CHF 390,000,000 aggregate principal amount of the Company's 1.560% Bonds 2025 – 2035 (Tranche B).

8-KOther EventsFiled Period of report Summary published (UTC)

Key points

AI summary
  1. On September 4, 2025, Zimmer Biomet issued 2 series of senior unsecured debt securities denominated in Swiss francs, comprising CHF 210,000,000 aggregate principal amount of the Company's 0.930% Bonds 2025 – 2030 (Tranche A) and CHF 390,000,000 aggregate principal amount of the Company's 1.560% Bonds 2025 – 2035 (Tranche B).

  2. The company said the Tranche A Bonds bear interest at 0.930% per annum and the Tranche B Bonds at 1.560% per annum, with interest payable annually in arrears on September 4 of each year, commencing on September 4, 2026. The Tranche A Bonds mature on September 4, 2030 and the Tranche B Bonds mature on September 4, 2035.

  3. Zimmer Biomet said each tranche of the Bonds is subject to "3-months par call" and "clean-up call" provisions, pursuant to which the Company may redeem such tranche in whole, but not in part, at par at any time on or after June 4, 2030 in the case of the Tranche A Bonds or June 4, 2035 in the case of the Tranche B Bonds, or if 85% or more of the aggregate principal amount of such tranche has been redeemed or purchased and cancelled.

  4. The company will pay additional amounts so that holders who are not United States persons receive the net payment provided in the Bonds after any required withholding or deduction for United States taxes, subject to certain exceptions and limitations, and holders may require the company to repurchase their Bonds at par upon a Change of Control Triggering Event.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Issuance of 2 Series of Senior Unsecured Debt Securities Denominated in Swiss Francs

On September 4, 2025, Zimmer Biomet issued 2 series of senior unsecured debt securities denominated in Swiss francs, comprising CHF 210,000,000 aggregate principal amount of the Company's 0.930% Bonds 2025 – 2030 (Tranche A) and CHF 390,000,000 aggregate principal amount of the Company's 1.560% Bonds 2025 – 2035 (Tranche B).

Source · Based on the filing body and exhibits

Coupon Rates and Maturity Structure

The company said the Tranche A Bonds bear interest at 0.930% per annum and the Tranche B Bonds at 1.560% per annum, with interest payable annually in arrears on September 4 of each year, commencing on September 4, 2026. The Tranche A Bonds mature on September 4, 2030 and the Tranche B Bonds mature on September 4, 2035.

Source · Based on the filing body and exhibits

Early Redemption Provisions

Zimmer Biomet said each tranche of the Bonds is subject to "3-months par call" and "clean-up call" provisions, pursuant to which the Company may redeem such tranche in whole, but not in part, at par at any time on or after June 4, 2030 in the case of the Tranche A Bonds or June 4, 2035 in the case of the Tranche B Bonds, or if 85% or more of the aggregate principal amount of such tranche has been redeemed or purchased and cancelled.

Source · Based on the filing body and exhibits

Additional Payment Obligations and Repurchase Rights Upon Change of Control

The company will pay additional amounts so that holders who are not United States persons receive the net payment provided in the Bonds after any required withholding or deduction for United States taxes, subject to certain exceptions and limitations, and holders may require the company to repurchase their Bonds at par upon a Change of Control Triggering Event.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.